NASOCLENZ- benzalkonium chloride 0.13% gel

NasoClenz by

Drug Labeling and Warnings

NasoClenz by is a Otc medication manufactured, distributed, or labeled by Silicon Valley Innovations, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

NasoClenz Cleansing Kit Drug Facts

Active Ingredient

Benzalkonium chloride (0.13%)

Uses

• Helps reduce bacteria that can cause skin infections

INDICATIONS & USAGE

• Antiseptic preparation to decrease bacteria on skin

Warnings

For external use only, do not ingest.

Do Not Use

• If you are allergic to any of the ingredients
• In or near the eyes
• On children under 2 years of age

Ask a doctor before use if you have

• Deep or puncture wounds
• Serious burns

Stop use and ask a doctor if

• Irritation, swelling, pain or other symptoms develop

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

1. Apply gel to tip of Cleansing Wand
2. Insert tip with gel into nostril, rotating it in each direction several times
3. Wipe any excess gel from nose with a tissue

DOSAGE & ADMINISTRATION

• Use every 4-8 hours as needed
• Children under age 12 use with adult supervision

Other Information

Protect from excessive heat (temperatures about 104°F/40°C)

Inactive Ingredients - 81900-013

Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Propylene Glycol, Triethanolamine, Water

Inactive Ingredients - 81900-014

Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Peppermint Oil, Propylene Glycol, Triethanolamine, Water

Questions?

Call 1-844-4MY-NASO

OR (1-844-469-6276)

M-F 9am to 5pm PST

NasoClenz.com

Principal Display Panel - 81900-013

Principal Display Panel - 81900-014

INGREDIENTS AND APPEARANCE

NASOCLENZ 
benzalkonium chloride 0.13% gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 81900-014
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	1.19 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
WATER (UNII: 059QF0KO0R)
GLYCERIN (UNII: PDC6A3C0OX)
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)
TROLAMINE (UNII: 9O3K93S3TK)
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: F68VH75CJC)
PEPPERMINT OIL (UNII: AV092KU4JH)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 81900-014-03	1 in 1 BOX	09/25/2023
1		12 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
2	NDC: 81900-014-04	2 in 1 BOX	09/25/2023
2		1 in 1 POUCH
2		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
3	NDC: 81900-014-05	4 in 1 BOX	09/25/2023
3		1 in 1 POUCH
3		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
4	NDC: 81900-014-06	1 in 1 BOX	02/16/2024
4		5 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
5	NDC: 81900-014-08	1 in 1 BOX	05/26/2025
5		12 mL in 1 TUBE; Type 7: Separate Products Requiring Cross Labeling

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	09/25/2023

NASOCLENZ 
benzalkonium chloride 0.13% gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 81900-013
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	1.19 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
TROLAMINE (UNII: 9O3K93S3TK)
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: F68VH75CJC)
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)
GLYCERIN (UNII: PDC6A3C0OX)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 81900-013-03	1 in 1 BOX	07/15/2022
1		12 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
2	NDC: 81900-013-04	2 in 1 BOX	07/15/2022
2		1 in 1 POUCH
2		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
3	NDC: 81900-013-05	4 in 1 BOX	07/15/2022
3		1 in 1 POUCH
3		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
4	NDC: 81900-013-60	60 in 1 BOX	11/15/2022
4		1 in 1 POUCH
4		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
5	NDC: 81900-013-01	40 in 1 BOX	11/01/2021
5		1 in 1 POUCH
5		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
6	NDC: 81900-013-02	8 in 1 BOX	11/01/2021
6		1 in 1 POUCH
6		1 mL in 1 POUCH; Type 1: Convenience Kit of Co-Package
7	NDC: 81900-013-06	1 in 1 BOX	02/16/2024
7		5 mL in 1 TUBE; Type 1: Convenience Kit of Co-Package
8	NDC: 81900-013-08	1 in 1 BOX	05/26/2025
8		12 mL in 1 TUBE; Type 7: Separate Products Requiring Cross Labeling

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	11/01/2021

Labeler - Silicon Valley Innovations, Inc. (118048729)

Registrant - Silicon Valley Innovations, Inc. (118048729)

Establishment
Name	Address	ID/FEI	Business Operations
Silicon Valley Innovations, Inc.		118048729	label(81900-013, 81900-014) , pack(81900-013, 81900-014)